Dr. Michelle Gong is recognized nationally and internationally for her expertise in critical care research. A model clinician-researcher, her scientific projects influence her clinical care, and her patients influence her research. Her overall research focus has been on the prediction and prevention of acute critical illness and their complications. Continuously funded by the NIH for over 10 years for her research, her current projects range from acute respiratory distress syndrome (ARDS) to prevention of delirium, treatment of severe influenza and the development of new electronic acute care interfaces.
Dr. Gong is the Director of Critical Care Research in the Division of Critical Care Medicine at Montefiore Medical Center and Associate Professor in Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009.
Current and past research projects under Dr. Gong’s direction include:
- Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network: Einstein/Montefiore, under the leadership of Dr. Gong, was selected as a participating clinical center in the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network. This Network, funded by the National Heart, Lung and Blood Institute (NHLBI), will develop and conduct clinical trials to prevent, treat, and/or improve the outcome of adult patients with, or at risk for ARDS.
- ProCCESs AWARE - Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation: This is a collaboration with Mayo Clinic to pioneer and implement a novel acute care interface with built-in tools for error prevention, practice surveillance, decision support and reporting. Funded by the Centers for Medicare & Medicaid Services, this project uses a cloud-based technology to provide clinicians with real time point of care critical information necessary for effective medical decision making and prevention of ICU-acquired complications.
- The MIND-USA Study (in collaboration with NHLBI and Vanderbilt University) is a multicenter, double blind, randomized control three arm trial aimed to determine the utility of haloperidol, ziprasidone, or placebo to reduce delirium and coma free days in patients in the intensive care unit.
- LIPS-A: Lung Injury Prevention Study with Aspirin (in collaboration with NHLBI and Mayo Clinic) is a multicenter, double blind, randomized control trial aimed to determine the safety and utility of aspirin to decrease development of acute lung injury and other pulmonary and non-pulmonary organ failure in patients determined to be a high risk for lung injury.
- EPVent2 (in collaboration with NHLBI and Beth Israel Deaconness) is a randomized control trial aimed to determine whether the use of esophageal guided mechanical ventilation in patients with ALI/ARDS will decrease mortality in lung injury.
- A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational anti-Influenza Immune Plasma for the Treatment of Influenza is being undertaken in collaboration with NIAID and Social & Scientific Systems, Inc. to investigate a novel treatment for severe, high risk influenza infection.
An award-winning educator, Dr. Gong has received the National Institutes of Health’s (NIH) Health Disparity Scholar Award and the Mentored Patient-Oriented Research Career Development Award.